Precipio, Inc. (NASDAQ:PRPO) Short Interest Update

Precipio, Inc. (NASDAQ:PRPO) saw a significant drop in short interest in December. As of December 15th, there was short interest totalling 3,200 shares, a drop of 30.4% from the November 30th total of 4,600 shares. Approximately 0.3% of the company’s shares are short sold. Based on an average trading volume of 7,100 shares, the short-interest ratio is currently 0.5 days.

Precipio Price Performance

NASDAQ:PRPO opened at $5.51 on Friday. The firm has a market capitalization of $8.17 million, a price-to-earnings ratio of -3.01 and a beta of 1.40. The company has a debt-to-equity ratio of 0.02, a current ratio of 0.73 and a quick ratio of 0.60. The business has a 50 day simple moving average of $5.98 and a 200-day simple moving average of $5.87. Precipio has a 1 year low of $4.31 and a 1 year high of $7.30.

Precipio Company Profile

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.